These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 26132818)

  • 1. The Low-Cost Compound Lignosulfonic Acid (LA) Exhibits Broad-Spectrum Anti-HIV and Anti-HSV Activity and Has Potential for Microbicidal Applications.
    Gordts SC; Férir G; D'huys T; Petrova MI; Lebeer S; Snoeck R; Andrei G; Schols D
    PLoS One; 2015; 10(7):e0131219. PubMed ID: 26132818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The lantibiotic peptide labyrinthopeptin A1 demonstrates broad anti-HIV and anti-HSV activity with potential for microbicidal applications.
    Férir G; Petrova MI; Andrei G; Huskens D; Hoorelbeke B; Snoeck R; Vanderleyden J; Balzarini J; Bartoschek S; Brönstrup M; Süssmuth RD; Schols D
    PLoS One; 2013; 8(5):e64010. PubMed ID: 23724015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanistic Studies of Viral Entry: An Overview of Dendrimer-Based Microbicides As Entry Inhibitors Against Both HIV and HSV-2 Overlapped Infections.
    Sepúlveda-Crespo D; Ceña-Díez R; Jiménez JL; Ángeles Muñoz-Fernández M
    Med Res Rev; 2017 Jan; 37(1):149-179. PubMed ID: 27518199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of HIV-1 entry inhibitors with broad activity against R5 and X4 viral strains.
    Sironi F; Malnati M; Mongelli N; Cozzi P; Guzzo C; Ghezzi S; Martínez-Romero C; García-Sastre A; Lusso P; Jabes D; Biswas P
    J Transl Med; 2015 Apr; 13():107. PubMed ID: 25888743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A unique class of lignin derivatives displays broad anti-HIV activity by interacting with the viral envelope.
    Oeyen M; Noppen S; Vanhulle E; Claes S; Myrvold BO; Vermeire K; Schols D
    Virus Res; 2019 Dec; 274():197760. PubMed ID: 31618614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Vaginal Acquisition and Dissemination of HIV-1 Infection in a Novel Transgenic Mouse Model Is Facilitated by Coinfection with Herpes Simplex Virus 2 and Is Inhibited by Microbicide Treatment.
    Seay K; Khajoueinejad N; Zheng JH; Kiser P; Ochsenbauer C; Kappes JC; Herold B; Goldstein H
    J Virol; 2015 Sep; 89(18):9559-70. PubMed ID: 26157126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RD6-2198, a novel betain-type fluoroalkylated oligomer, inhibits the replications of human immunodeficiency virus type 1 and other enveloped viruses.
    Fujiwara M; Ashida N; Okamoto M; Mizuta T; Ide T; Hanasaki Y; Katsuura K; Sawada H; Shigeta S; Konno K; Yokota T; Baba M
    Antiviral Res; 1998 May; 38(2):141-9. PubMed ID: 9707376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poly (4-styrenesulfonic acid-co-maleic acid) is an entry inhibitor against both HIV-1 and HSV infections - potential as a dual functional microbicide.
    Qiu M; Chen Y; Song S; Song H; Chu Y; Yuan Z; Cheng L; Zheng D; Chen Z; Wu Z
    Antiviral Res; 2012 Nov; 96(2):138-47. PubMed ID: 22940611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lignosulfonic acid exhibits broadly anti-HIV-1 activity--potential as a microbicide candidate for the prevention of HIV-1 sexual transmission.
    Qiu M; Wang Q; Chu Y; Yuan Z; Song H; Chen Z; Wu Z
    PLoS One; 2012; 7(4):e35906. PubMed ID: 22558266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Griffithsin and Carrageenan Combination To Target Herpes Simplex Virus 2 and Human Papillomavirus.
    Levendosky K; Mizenina O; Martinelli E; Jean-Pierre N; Kizima L; Rodriguez A; Kleinbeck K; Bonnaire T; Robbiani M; Zydowsky TM; O'Keefe BR; Fernández-Romero JA
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7290-8. PubMed ID: 26369967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapamycin reduces CCR5 density levels on CD4 T cells, and this effect results in potentiation of enfuvirtide (T-20) against R5 strains of human immunodeficiency virus type 1 in vitro.
    Heredia A; Gilliam B; Latinovic O; Le N; Bamba D; Devico A; Melikyan GB; Gallo RC; Redfield RR
    Antimicrob Agents Chemother; 2007 Jul; 51(7):2489-96. PubMed ID: 17485501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Herbal Gel Formulation Developed for Anti-Human Immunodeficiency Virus (HIV)-1 Activity Also Inhibits In Vitro HSV-2 Infection.
    Mishra NN; Kesharwani A; Agarwal A; Polachira SK; Nair R; Gupta SK
    Viruses; 2018 Oct; 10(11):. PubMed ID: 30352961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel, negatively charged, human serum albumins display potent and selective in vitro anti-human immunodeficiency virus type 1 activity.
    Jansen RW; Schols D; Pauwels R; De Clercq E; Meijer DK
    Mol Pharmacol; 1993 Nov; 44(5):1003-7. PubMed ID: 7902528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sulfated polysaccharides extracted from sea algae as potential antiviral drugs.
    Witvrouw M; De Clercq E
    Gen Pharmacol; 1997 Oct; 29(4):497-511. PubMed ID: 9352294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feglymycin, a unique natural bacterial antibiotic peptide, inhibits HIV entry by targeting the viral envelope protein gp120.
    Férir G; Hänchen A; François KO; Hoorelbeke B; Huskens D; Dettner F; Süssmuth RD; Schols D
    Virology; 2012 Nov; 433(2):308-19. PubMed ID: 22959895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbosilane dendrons with fatty acids at the core as a new potential microbicide against HSV-2/HIV-1 co-infection.
    Guerrero-Beltrán C; Ceña-Diez R; Sepúlveda-Crespo D; De la Mata J; Gómez R; Leal M; Muñoz-Fernández MA; Jiménez JL
    Nanoscale; 2017 Nov; 9(44):17263-17273. PubMed ID: 29090302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure activity relationship of dendrimer microbicides with dual action antiviral activity.
    Tyssen D; Henderson SA; Johnson A; Sterjovski J; Moore K; La J; Zanin M; Sonza S; Karellas P; Giannis MP; Krippner G; Wesselingh S; McCarthy T; Gorry PR; Ramsland PA; Cone R; Paull JR; Lewis GR; Tachedjian G
    PLoS One; 2010 Aug; 5(8):e12309. PubMed ID: 20808791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphoramidate derivatives of acyclovir: synthesis and antiviral activity in HIV-1 and HSV-1 models in vitro.
    Zakirova NF; Shipitsyn AV; Jasko MV; Prokofjeva MM; Andronova VL; Galegov GA; Prassolov VS; Kochetkov SN
    Bioorg Med Chem; 2012 Oct; 20(19):5802-9. PubMed ID: 22954898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new class of dual-targeted antivirals: monophosphorylated acyclovir prodrug derivatives suppress both human immunodeficiency virus type 1 and herpes simplex virus type 2.
    Vanpouille C; Lisco A; Derudas M; Saba E; Grivel JC; Brichacek B; Scrimieri F; Schinazi R; Schols D; McGuigan C; Balzarini J; Margolis L
    J Infect Dis; 2010 Feb; 201(4):635-43. PubMed ID: 20085496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo evaluations of sodium lauryl sulfate and dextran sulfate as microbicides against herpes simplex and human immunodeficiency viruses.
    Piret J; Lamontagne J; Bestman-Smith J; Roy S; Gourde P; Désormeaux A; Omar RF; Juhász J; Bergeron MG
    J Clin Microbiol; 2000 Jan; 38(1):110-9. PubMed ID: 10618073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.